electrophoresis
Rna Diagnostics Completes Phase I Trial for Breast Cancer Treatment Test, Aims for 2025 Launch
Premium
The firm's RNA Disruption Assay measures ribosomal RNA fragmentation to determine whether a cancer treatment is working and aid decisions whether to change course.
Thermo Fisher Signs Comarketing, Research Agreements for Mass Spec Applications
The company signed separate agreements with Newomics, Advanced Electrophoresis Solutions, and the University of Sheffield involving its mass spec and other technologies.
The Stanford University spinout claims it can get three times the nucleic acid yield as column- or magnetic bead-based methods, with less damage to the molecules.
Rna Diagnostics is hoping to make its RDA assay available as a laboratory-developed test for research use next year before offering it to clinicians in 2020.
The team's method utilizes two plasmids that produce DNA fragments from 50 to 1,000 bp, and are available through the nonprofit organization AddGene.